Impact of Sleep Disorders and Digital Support on Older People's Health
NCT ID: NCT06944600
Last Updated: 2025-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
300 participants
OBSERVATIONAL
2025-05-31
2027-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is: How do sleep disorders impact the motoric and cognitive ageing trajectories of older individuals? Participants will undergo a set of instrumental, laboratory and clinical diagnostic examinations to comprehensively assess the impact of sleep disorders on health.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aging, Sleep, Cognitive Process
NCT00804804
Efficacy of Sleep Hygiene Intervention in Elderly With Insomnia
NCT06652789
Prevalence of Sleep Disturbances in Elderly People Hospitalized in Medicine, Psychiatry and Rehabilitation Departments: TOPASE Prospective Study, RIPH 3
NCT06659575
Sleep, Cognition and Memory Disorder
NCT01650454
Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
NCT06457945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physically frail sarcopenic older subjects
No interventions assigned to this group
Healthy active older subjects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MMSE score adjusted by age and education ≥ 25/30;
* Absence of mobility-disability;
* Absence of need for assistance with Basic Activities of Daily Living (according to the ICFSR International Clinical Practice Guidelines).
Exclusion Criteria
* Individuals whose adherence to the protocol might be low due to clinical (E.g., cognitive impairment, dialysis) and non-clinical (E.g., plans to relocate out of the study area within the next 3 years) reasons;
* Individuals unable or unwilling to provide informed consent;
* Consumption of more than 14 alcoholic drinks per week \[one alcoholic drink (equal to 14.0 grams of pure alcohol) corresponds to 36 cc of beer (5% alcohol content), 24 cc of malt liquor (7% alcohol content), 15 cc of wine (12% alcohol content), 4.5 cc of distilled spirit or liquor (40% alcohol content)\];
* Difficulty in communicating with the study staff due to speech, language, or (non-corrected) hearing and vision problems;
* Severe arthritis (E.g., awaiting joint replacement) that would interfere with the ability to fully participate in the study;
* Lung disease requiring regular use of supplemental oxygen;
* Severe cardiovascular disease (including New York Heart Association \[NYHA\] class III or IV, clinically significant congestive heart failure and valvular disease, history of cardiac arrest, presence of an implantable defibrillator or pacemaker, uncontrolled angina);
* Upper and/or lower extremity amputation;
* Peripheral arterial disease Lériche-Fontaine 3 or 4;
* Renal disease requiring dialysis;
* Current enrolment in another study involving lifestyle, nutrition, or pharmaceutical interventions;
* Further medical, psychiatric, or behavioural factors that in the judgment of the principal investigator may interfere with the study participation;
* Further possible illnesses affecting the life expectancy and reducing it to less than 24 months, corresponding to the study's length;
* Clinical judgment concerning safety or non-compliance, as well as the conditions for which the use of the Sleep Profiler is not recommended (sensitivity of skin or scalp and/or open wounds on the forehead or scalp, allergic reactions to extended exposure to synthetic fabrics (e.g., polyester, rayon), upper respiratory infection or congestion, head circumference less than 21 or greater than 25 inches, forehead vertical measurement (from top of eyebrows to hairline) less than or equal to 2 inches or horizontal measurement (from hairline to hairline) less than or equal to 6 inches).
* SPPB score \<3 at baseline.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Parma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcello Giuseppe Maggio
MD, PhD, Full Professor in Internal and Geriatric Medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
262/2024/SPER/UNIPR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.